The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung

Tadashi Manabe MD, PhD on X: A whole new oncogenic driver in non

Oncogenic fusions in invasive mucinous LDAC. A, schematic

Recombinant Anti-LTK antibody [EPR5175(2)] (ab129155)

Histological findings of tumours positive for the CLIP1-LTK fusion

Oncogenic driver mutations in non-small cell lung cancer: Past

Unique Genetic Characteristics and Clinical Prognosis of Female

AMG-510 and cisplatin combination increases antitumor effect in lung adenocarcinoma with mutation of KRAS G12C: a preclinical and translational research

Biological and clinical perspectives of the actionable gene

PDF] Identification of a RAS-activating TMEM87A–RASGRF1 Fusion in

肺癌靶点研究渐露锋芒，源井生物基因编辑细胞助力肿瘤研究_源井生物

Biomolecules, Free Full-Text

The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung

Most frequently comutated genes with STK11 in non-small cell lung

肺癌靶点研究渐露锋芒，源井生物基因编辑细胞助力肿瘤研究_源井生物

Frontiers Recent progress in targeted therapy for non-small cell